Cargando…
Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086435/ https://www.ncbi.nlm.nih.gov/pubmed/37056342 http://dx.doi.org/10.3389/fonc.2023.1147497 |
| _version_ | 1785022152675688448 |
|---|---|
| author | Mauri, Gianluca Patelli, Giorgio Gori, Viviana Lauricella, Calogero Mussolin, Benedetta Amatu, Alessio Bencardino, Katia Tosi, Federica Bonazzina, Erica Bonoldi, Emanuela Bardelli, Alberto Siena, Salvatore Sartore-Bianchi, Andrea |
| author_facet | Mauri, Gianluca Patelli, Giorgio Gori, Viviana Lauricella, Calogero Mussolin, Benedetta Amatu, Alessio Bencardino, Katia Tosi, Federica Bonazzina, Erica Bonoldi, Emanuela Bardelli, Alberto Siena, Salvatore Sartore-Bianchi, Andrea |
| author_sort | Mauri, Gianluca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10086435 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100864352023-04-12 Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer Mauri, Gianluca Patelli, Giorgio Gori, Viviana Lauricella, Calogero Mussolin, Benedetta Amatu, Alessio Bencardino, Katia Tosi, Federica Bonazzina, Erica Bonoldi, Emanuela Bardelli, Alberto Siena, Salvatore Sartore-Bianchi, Andrea Front Oncol Oncology Frontiers Media S.A. 2023-03-28 /pmc/articles/PMC10086435/ /pubmed/37056342 http://dx.doi.org/10.3389/fonc.2023.1147497 Text en Copyright © 2023 Mauri, Patelli, Gori, Lauricella, Mussolin, Amatu, Bencardino, Tosi, Bonazzina, Bonoldi, Bardelli, Siena and Sartore-Bianchi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Mauri, Gianluca Patelli, Giorgio Gori, Viviana Lauricella, Calogero Mussolin, Benedetta Amatu, Alessio Bencardino, Katia Tosi, Federica Bonazzina, Erica Bonoldi, Emanuela Bardelli, Alberto Siena, Salvatore Sartore-Bianchi, Andrea Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer |
| title | Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer |
| title_full | Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer |
| title_fullStr | Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer |
| title_full_unstemmed | Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer |
| title_short | Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer |
| title_sort | corrigendum: case report: map2k1 k57n mutation is associated with primary resistance to anti-egfr monoclonal antibodies in metastatic colorectal cancer |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086435/ https://www.ncbi.nlm.nih.gov/pubmed/37056342 http://dx.doi.org/10.3389/fonc.2023.1147497 |
| work_keys_str_mv | AT maurigianluca corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT patelligiorgio corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT goriviviana corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT lauricellacalogero corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT mussolinbenedetta corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT amatualessio corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT bencardinokatia corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT tosifederica corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT bonazzinaerica corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT bonoldiemanuela corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT bardellialberto corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT sienasalvatore corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer AT sartorebianchiandrea corrigendumcasereportmap2k1k57nmutationisassociatedwithprimaryresistancetoantiegfrmonoclonalantibodiesinmetastaticcolorectalcancer |